| In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies IR Korponay-Szabó, T Halttunen, Z Szalai, K Laurila, R Király, JB Kovács, ... Gut 53 (5), 641-648, 2004 | 427 | 2004 |
| Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits TT Salmi, P Collin, IR Korponay-Szabo, K Laurila, J Partanen, H Huhtala, ... Gut 55 (12), 1746-1753, 2006 | 307 | 2006 |
| Protein transamidation by transglutaminase 2 in cells: a disputed Ca2+‐dependent action of a multifunctional protein R Király, MÁ Demény, L Fésüs The FEBS journal 278 (24), 4717-4739, 2011 | 99 | 2011 |
| Functional significance of five noncanonical Ca2+‐binding sites of human transglutaminase 2 characterized by site‐directed mutagenesis R Király, É Csősz, T Kurtán, S Antus, K Szigeti, Z Simon‐Vecsei, ... The FEBS journal 276 (23), 7083-7096, 2009 | 94 | 2009 |
| Coeliac disease case finding and diet monitoring by point‐of‐care testing IR KORPONAY‐SZABÓ, T Raivio, K Laurila, J Opre, R Kiraly, JB Kovács, ... Alimentary pharmacology & therapeutics 22 (8), 729-737, 2005 | 93 | 2005 |
| Transglutaminase 2 in human diseases Z Szondy, I Korponay-Szabó, R Király, Z Sarang, GJ Tsay BioMedicine 7 (3), 2017 | 78 | 2017 |
| A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects Z Simon-Vecsei, R Király, P Bagossi, B Tóth, I Dahlbom, S Caja, É Csősz, ... Proceedings of the National Academy of Sciences 109 (2), 431-436, 2012 | 78 | 2012 |
| Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize IR Korponay-Szabó, Z Vecsei, R Király, I Dahlbom, F Chirdo, É Nemes, ... Journal of pediatric gastroenterology and nutrition 46 (3), 253-261, 2008 | 75 | 2008 |
| Coeliac autoantibodies can enhance transamidating and inhibit GTPase activity of tissue transglutaminase: dependence on reaction environment and enzyme fitness R Király, Z Vecsei, T Deményi, IR Korponay-Szabó, L Fésüs Journal of autoimmunity 26 (4), 278-287, 2006 | 60 | 2006 |
| Identification of a specific one amino acid change in recombinant human transglutaminase 2 that regulates its activity and calcium sensitivity K Kanchan, E Ergülen, R Király, Z Simon-Vecsei, M Fuxreiter, L Fésüs Biochemical Journal 455 (3), 261-272, 2013 | 39 | 2013 |
| Isopeptidase activity of human transglutaminase 2: disconnection from transamidation and characterization by kinetic parameters R Király, K Thangaraju, Z Nagy, R Collighan, Z Nemes, M Griffin, L Fésüs Amino acids 48, 31-40, 2016 | 27 | 2016 |
| Metastasis-associated S100A4 is a specific amine donor and an activity-independent binding partner of transglutaminase-2 B Biri, B Kiss, R Király, G Schlosser, O Láng, L Kőhidai, L Fésüs, L Nyitray Biochemical Journal 473 (1), 31-42, 2016 | 18 | 2016 |
| Transglutaminase 2 dysfunctions in the development of autoimmune disorders: celiac disease and TG2-/-mouse Z Szondy, I Korponay-Szabó, R Király, L Fésüs Advances in enzymology and related areas of molecular biology 78, 295, 2011 | 18 | 2011 |
| Juvenile Huntington’s Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological … A Aladdin, R Király, P Boto, Z Regdon, K Tar International Journal of Molecular Sciences 20 (21), 5338, 2019 | 17 | 2019 |
| Polymorphism of transglutaminase 2: unusually low frequency of genomic variants with deficient functions R Király, E Barta, L Fésüs Amino Acids 44, 215-225, 2013 | 14 | 2013 |
| Caspase‐9 acts as a regulator of necroptotic cell death T Molnár, P Pallagi, B Tél, R Király, E Csoma, V Jenei, Z Varga, ... The FEBS Journal 288 (22), 6476-6491, 2021 | 9 | 2021 |
| Irisin Stimulates the Release of CXCL1 From Differentiating Human Subcutaneous and Deep-Neck Derived Adipocytes via Upregulation of NFκB Pathway A Shaw, BB Tóth, R Király, R Arianti, I Csomós, S Póliska, A Vámos, ... Frontiers in Cell and Developmental Biology 9, 737872, 2021 | 8 | 2021 |
| Real-time kinetic method to monitor isopeptidase activity of transglutaminase 2 on protein substrate K Thangaraju, B Biri, G Schlosser, B Kiss, L Nyitray, L Fésüs, R Király Analytical Biochemistry 505, 36-42, 2016 | 8 | 2016 |
| Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction Á Diós, R Elek, I Szabó, S Horváth, J Gyimesi, R Király, K Werkstetter, ... Amino Acids 53 (7), 1051-1063, 2021 | 7 | 2021 |
| Genomic variants reveal differential evolutionary constraints on human transglutaminases and point towards unrecognized significance of transglutaminase 2 K Thangaraju, R Király, MA Demeny, J András Mótyán, M Fuxreiter, ... PloS one 12 (3), e0172189, 2017 | 7 | 2017 |
